WONDFO BIOTECH(SZ:300482)2022-12-04 08:26Group 1: Financial Performance and Market Insights - The gross margin for pregnancy products is relatively low, primarily due to changes in procurement patterns influenced by the economic crisis in Europe, where high-margin products are being replaced by lower-margin alternatives [2][3] - Domestic market growth is approximately over 50%, with significant contributions from clinical hospital markets, disease control tender markets, and OTC markets [4][5] - The company anticipates steady growth in pregnancy product sales due to the national two-child policy [3][4] Group 2: Product Development and Innovation - New products are expected to launch in December, including a blood gas testing system, with additional products in the pipeline for the following year [4][5] - The company is focusing on developing products for chronic diseases, including cardiovascular and respiratory diseases, indicating a significant growth potential in this area [5][6] - The introduction of microfluidic technology is expected to enhance product sensitivity and specificity, although it may increase costs [10][11] Group 3: Strategic Partnerships and Collaborations - The company is financially investing in AG Company and collaborating in market research, development, and manufacturing [3][4] - Plans to establish regional testing centers in collaboration with local health departments to integrate medical resources and improve service delivery [6][7] - The company is open to acquiring small overseas startups if suitable opportunities arise [5][6] Group 4: Market Strategy and Distribution Channels - The company does not exclusively target top-tier hospitals but allocates resources based on product characteristics and market acceptance in various hospital tiers [7][8] - The focus on channel mergers is shifting towards terminal aspects, with an emphasis on building regional testing centers to enhance service and sales [8][9] - The pharmacy channel is not a primary focus, with limited product offerings in this area, particularly for chronic disease products [10][11]